Search for Abstracts Find by Title, Author or Description Year Abstracts - 2022 - 2021 - 2020 - 2019 - 2018 - 2017 - 2016 - 2015 - 2014 - 2013 - 2012 - 2011 - 2010 - 2009 Tags AB Applied Basic Science Basic Science BT Clinical Clinical-Chemotherapy-SSA-Biologics Clinical-PRRT-Nuclear Clinical-Surgical-Applied_Pathology OT Other P Population Science Poster T Trials In Progress Search Reset Order by Title Alphabetical Title Reverse Alphabetical Most Recent First Oldest First Most popular first Last modified first B01 – The Genomic Landscape of Small Intestine Neuroendocrine Tumors Published in 2013 Listed under Basic Science Download Banck B02 – Somatic Mutations in Inherited Pheochromocytomas and Paragangliomas Published in 2013 Listed under Basic Science Download Fishbein B03 – A Multi-Gene Transcript Blood Molecular Signature for the Detection and Treatment of Gut Neuroendocrine Tumors Published in 2013 Listed under Basic Science Download Kidd B04 – Specific Glycogen Synthase Kinase-3 Inhibition Suppresses Growth and Reduces the Neuroendocrine Tumor Markers in Neuroblastoma Cells Published in 2013 Listed under Basic Science Download Kunnimalaiyaan B05 – Gastric Inhibitory Polypeptide Receptor (GIPR): A Future Alternative to Somatostatin Type 2 Receptor Imaging and Treatment in Neuroendocrine Tumors? Published in 2013 Listed under Basic Science Download Sherman B06 – PI3K-AKT-mTOR Pathway Disregulation and its Correlation with Clinical Outcome in Patients with Advanced Neuroendocrine Tumors Treated with Everolimus Published in 2013 Listed under Basic Science Download Spada B07 – A Primary Xenograft Model of Pancreatic Neuroendocrine Carcinoma Recapitulates Hallmark Features of the Disease Published in 2013 Listed under Basic Science Download Wang B08 – Aberrant Activation of DNA methyltransferase 1 (DNMT1) Mediated Global DNA Methylation and Implicates Sox/Wnt/β-Catenin Signaling Pathway in the Multiple Endocrine Neoplasm Type 1 (MEN1) Syndrome Published in 2013 Listed under Basic Science Download Yuan C01 – Czech Registery of Neuroendocrine Neoplasms (NEN) Published in 2013 Listed under Clinical Download Barkmanova C02 – A Systematic Literature Review on the Efficacy and Safety of Octreotide Long-Acting Repeatable Used at Higher than FDA-Approved Doses and/or Frequencies for Treatment of Neuroendocrine Tumors Published in 2013 Listed under Clinical Download Broder C03 – Octreotide LAR in Patients with Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH): A Case Series Published in 2013 Listed under Clinical Download Byron C04 – Lanreotide Autogel Significantly Improves Tumor Progression-Free Survival in Patients with Non-Functioning Gastroenteropancreatic Neuroendocrine Tumors: Results of the CLARINET Study Published in 2013 Listed under Clinical Download Caplin C05 – Succinate Dehydrogenase Subunit B (SDHB) Immunohistochemistry Should Not Replace Clinical Genetic Testing for SDHx Mutations in Patients with Pheochromocytoma and Paraganglioma Published in 2013 Listed under Clinical Download Fishbein C06 – Cumulative Safety Experience of Telotristat Etiprate in Clinical Trials Supports Advancement to Phase 3 Published in 2013 Listed under Clinical Download Fleming C07 – Unusual Case of a Hormone-Secreting SDHC Head and Neck Paraganglioma Published in 2013 Listed under Clinical Download Ghayee C08 – Moving 68Ga-labeled DOTA PET Imaging Agents Towards Approval Published in 2013 Listed under Clinical Download Graham C09 – A Phase I Study of Imatinib, Dacarbazine, and Capecitabine in Advanced Endocrine Cancers Published in 2013 Listed under Clinical Download Halperin C10 – Clinical Presentation and Management of Patients with Bone Metastases (BMet) from Neuroendocrine Tumors (NETs): Pooled Results from Two Institutional Databases Published in 2013 Listed under Clinical Download Keiser C11 – SDHB Pheochromocytoma and Paraganglioma Penetrance in a United States Population: An NIH Study Published in 2013 Listed under Clinical Download King C12 – Dose-Escalation of Octreotide-LAR in Patients with Neuroendocrine Tumors (NET) Published in 2013 Listed under Clinical Download Kulke C13 – Patient-Reported Symptom Experiences Following Participation in a Study of Telotristat Etiprate for Patients with Carcinoid Tumor and Octreotide-Refractory Diarrhea Published in 2013 Listed under Clinical Download Kulke C14 – Comparison of 68Ga-DOTATATE (Ga) PET/CT with 111In-Octreotide (Octreoscan) SPECT in Somatastatin Positive Neuroendocrine Tumors (NET) Published in 2013 Listed under Clinical Download Kumar C15 – Patterns of Hepatic Metastases in Midgut Carcinoid: Diffuse Micrometastases and Disease Recurrence Published in 2013 Listed under Clinical Download Liu C16 – Neuroendocrine Tumors Arising in Meckel's Diverticula: Frequency of Advanced Disease Warrants Aggressive Management Published in 2013 Listed under Clinical Download Lorenzen C17 – 5-Fluorouracile/Capecitabine and Oxaliplatin (FOLFOX/XELOX) Suitable Treatments for Progressing G1-G2 Neuroendocrine Tumors Published in 2013 Listed under Clinical Download Marconcini C18 – Neuroendocrine Tumors Treated with Lanreotide After First Line Treatment with Octreotide LAR: A Single Center Experience Published in 2013 Listed under Clinical Download Marconcini C19 – Recurrence After Complete Resection of Gastrointestinal (GNET) or Pancreatic Neuroendocrine Tumors (PNET): Single Center Analysis Published in 2013 Listed under Clinical Download Marconcini C20 – Single Center Experience of Everolimus (Ev) Treatment in Pretreated Metastatic Well Differentiated Gastrointestinal (GNET) and Pancreatic Neuroendocrine Tumors (PNET) Published in 2013 Listed under Clinical Download Marconcini C21 – Somatostatine Analogs (SSA) Treatment in Well Differentiated Gastroenteropancreatic NeuroendocrineTumors (GEP-NET): A Single Centre Experience Published in 2013 Listed under Clinical Download Marconcini C22 – Association of Urinary Bladder Paragangliomas with Germline Mutations in the SDHB and VHL Genes Published in 2013 Listed under Clinical Download Martucci C23 – Gallium-68 DOTATOC PET-CT for Localization of Primary Tumor in Patients with Metastatic Neuroendocrine Tumors Published in 2013 Listed under Clinical Download Menda C24 – The Diagnostic Utility of Gallium-68 DOTATOC PET-CT in Patients with Suspected Neuroendocrine Tumors Published in 2013 Listed under Clinical Download Menda C25 – Tumor Shrinkage in a Patient with Cushing's Disease Treated with Pasireotide: A Clinical Case Report Published in 2013 Listed under Clinical Download Moloney C26 – Comparison of Manual and Automatic Methods of Ki-67 Proliferation Index For Neuroendocrine Tumors: The Development and Validation of a Novel Digital Pathology Tool (Ki67Counter) Published in 2013 Listed under Clinical Download Neltner C27 – Safety and Quality-Of-Life (QOL) Assessments in the Open-Label, Multicenter, Phase 3b, Expanded Access Study of Everolimus in Patients with Advanced Neuroendocrine Tumors (NET) Published in 2013 Listed under Clinical Download Pavel C28 – Phase 1 Maximum-Tolerated Dose Study of Pasireotide LAR in Patients with Advanced Neuroendocrine Tumors Published in 2013 Listed under Clinical Download Phan C29 – Efficacy and Safety of Everolimus in Patients with Advanced Low- or Intermediate-grade Pancreatic Neuroendocrine Tumors Previously Treated with Chemotherapy: A Subgroup Analysis of the RADIANT-3 Trial Published in 2013 Listed under Clinical Download Pommier C30 – Tumor Expression of VEGFA and Its Receptors and Clinical Outcomes in Neuroendocrine Tumors Published in 2013 Listed under Clinical Download Qian C31 – A Phase I/II Dose Escalation Study of TKM-080301, a RNAi Therapeutic Directed Against PLK1, in Patients with Advanced Solid Tumors, with an Expansion Cohort of Patients with NET or ACC Published in 2013 Listed under Clinical Download Ramanathan C32 – Bronchial Carcinoid Tumors: A Single Institution Review Published in 2013 Listed under Clinical Download Ramirez C33 – Development of AminoMedixTM, a Kidney Protective Agent During Peptide Receptor Radionuclide Therapy (PRRT) in Neuroendocrine Cancers Published in 2013 Listed under Clinical Download Ranganthan C34 – Survival in the Pre- and Post-Octreotide LAR Era in Carcinoid Syndrome Patients Published in 2013 Listed under Clinical Download Ray C35 – A Phase II Clinical and Translational Study of MK-2206 in Patients with Metastatic Neuroendocrine Tumors (NETs) Published in 2013 Listed under Clinical Download Reidy C36 – MIBG Avidity and Therapy in a Metastatic GI Neuroendocrine Tumor Patient Cohort Published in 2013 Listed under Clinical Download Riff C37 – Systemic Toxicity after Delayed Peptide Receptor Radionuclide Therapy in Patients with Metastatic Neuroendocrine Tumors Published in 2013 Listed under Clinical Download Riff C38 – Is Renal Toxicity From Y-90 DOTATOC Dependent Upon Dose per PRRT Treatment? Published in 2013 Listed under Clinical Download Sharma C39 – Tumor Heterogeneity in Small Intestine Neuroendocrine Tumors Metastatic to the Liver Published in 2013 Listed under Clinical Download Shi C40 – Von Recklinghausen's Disease and Pheochromocytoma: A Ten-Year Experience Published in 2013 Listed under Clinical Download Shinall C41 – Retrospective Review of Patients with Metastatic High Grade Neuroendocrine Carcinoma of the Pancreas: Memorial Sloan-Kettering Cancer Center Experience (MSKCC) Published in 2013 Listed under Clinical Download Shum C42 – Capecitabine Plus Temozolomide (CAP-TEM) in Patients with Advanced Neuroendocrine Tumors (NETs): An Italian Multicenter Retrospective Analysis Published in 2013 Listed under Clinical Download Spada C43 – Increased Incidence of Second Malignancy in Patients with Neuroendocrine Tumours (NETs) of the Ileum and Colon (MGC) Published in 2013 Listed under Clinical Download Stronge C44 – Dosing Patterns for Octreotide LAR in Neuroendocrine Tumor (NET) Patients: NCCN NET Outcomes Database Published in 2013 Listed under Clinical Download Strosberg C45 – Exploratory Analysis of Early Response Signals Using Targeted Therapies for the Treatment of Advanced Carcinoid Tumor of the Kidney Published in 2013 Listed under Clinical Download Subbiah C46 – A Multicenter Phase II Trial Evaluating Safety and Efficacy of Activity Escalation with 177Lu-DOTA-TATE in Patients with Disseminated Neuroendocrine Tumors, Based on Detailed Dosimetry and Patient Selection Published in 2013 Listed under Clinical Download Sundlov C47 – Metastatic Recurrent Small Bowel "Carcinoid": The Role of Blood Neuroendocrine Transcript Analysis in Diagnosis and Management Published in 2013 Listed under Clinical Download Teixeira C48 – 68Ga-DOTATATE PET/CT Imaging for Evaluation of Neuroendocrine Tumors (NET): The Vanderbilt Experience Published in 2013 Listed under Clinical Download Walker C49 – Neuroendocrine Tumors (NETs) of Unknown Primary: Is Early Surgical Exploration and Aggressive Debulking Justifiable? Published in 2013 Listed under Clinical Download Wang C50 – The Diamagnetic Effects of Peritoneal Carcinomatosis in the Prognosis of Patients with Advanced Midgut Neuroendocrine Tumors Published in 2013 Listed under Clinical Download Wang C51 – Phase 1 Expansion Study of an Oral TORC1/TORC2 Inhibitor (CC-223) in Non-Pancreatic Neuroendocrine Tumors (NET) Published in 2013 Listed under Clinical Download Wolin C52 – A Multicenter, Randomized, Blinded, Phase 3 Study of Pasireotide LAR vs Octreotide LAR in Patients with Metastatic Neuroendocrine Tumors (NET) with Disease-Related Symptoms Inadequately Controlled by Somatostatin Analogs Published in 2013 Listed under Clinical Download Wolin C53 – Everolimus Plus Octreotide Long-Acting Repeatable (LAR) for the Treatment of Advanced Neuroendocrine Tumors (NET) Associated with Carcinoid Syndrome: Updated Overall Survival Results from RADIANT-2 Study Published in 2013 Listed under Clinical Download Yao C54 – The Immunohistochemical Expression of Islet 1 and PAX8 by Rectal Neuroendocrine Tumors Should be Taken into Account in the Differential Diagnosis of Metastatic Neuroendocrine Tumors of Unknown Primary Origin Published in 2013 Listed under Clinical Download Zhou Select the number of documents per page 5 10 15 20 25 30 50 100
